Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial

Taghreed Hirz1,2,3, Shenglin Mei4,5, Hirak Sarkar6

  • 1Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA. THIRZ@mgh.harvard.edu.

Nature Communications
|February 7, 2023
PubMed
Summary

This study details the prostate tumor microenvironment, revealing immune suppressive cells and high angiogenic activity in high-risk prostate cancer. Understanding these factors is crucial for developing new treatments to prevent disease recurrence and metastasis.